![](/img/cover-not-exists.png)
PSY18 COST-EFFECTIVENESS OF TOFACITINIB IN ACTIVE PSORIATIC ARTHRITIS AFTER ANTI-TUMOUR NECROSIS FACTOR (ANTI-TNF) FAILURE OR INTOLERANCE IN SPAIN
Cañete, J.D., Vázquez, M., Nicolas, J., Rebollo, F., Gómez, S., López, A., Gari, C., Peral, C.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2646
Date:
November, 2019
File:
PDF, 324 KB
2019